The project “Implementation of UAB “RDA SPOT” e-commerce model” is being implemented

In 2022 January 28 By order of the Minister of Economy and Innovation of the Republic of Lithuania no. 4-160 for UAB “RDA SPOT” project “UAB “RDA SPOT” e-commerce model implementation” is allocated EUR 49,912.50 in funding under the measure “The e-commerce model for COVID-19”.

The goal of the project is the implementation of customer self-service solutions by e-mail. trading platform. During the implementation of the project, it is planned to install a customer self-service system, where the customer will be able to order, track and manage the results of medical research.

UAB “RDA Spot” is an innovative company founded in 2008. The company’s activities include medical and health development, production, collection, packaging and marketing of care products Project no. 13.1.1-LVPA-K-860-01-907 “Implementation of UAB “RDA SPOT” e-commerce model” funded by the European Regional Development Fund as the European Union’s response to the COVID-19 pandemic tool.

Duration of project implementation: until 2023 November 30

“RDA Spot” is participating in the project “Presentation of the Company and Its Products in International Exhibitions”.

Exhibitions are the most effective way to introduce a new one to the market. Participation
IVD Medical Office to present to a large number of medical professionals in a very short time
world, reach potential customers and partners, identify new sales channels, and get direct feedback on IVD the relevance of the medical device, customer needs and opportunities for improvement. Participation in the biggest presentation at medical exhibitions and its products, and in the second year, to strengthen the image and strengthen the position of the product and the brand, European and Asian markets.

Project no. 03.2.1-LVPA-K-801-05-0262 is funded by Europe Regional Development Fund.

Project starts: 09/2019
Project ends: 12/2022

“RDA SPOT” has implemented the EU co-financed project “DBS Covid-19 test kit”

“RDA Spot” implemented the project in accordance with the European Union Funds Investment Operational Program for 2014–2020, Priority 3 “Promotion of Small and Medium Business Competitiveness” measure No. 03.3.1-LVPA-T-859 “COVID-19 Products LT”, project number 03.3.1-LVPA-T-859-01-0038. The project was funded as part of the European Union’s response to the COVID-19 pandemic.

The result achieved after project implementation – DBS Covid-19 antibodies test kit.

The investment of EUR 468,397.50 has been allocated from the European Regional Development Fund for the implementation of the project.

The project started 02/2021, implementation period – 2 months.